You are here

UK

Novartis hit with another serious drug marketing breach, this time for multiple sclerosis therapy Mayzent

Fierce Pharma

Thu, 09/21/23 - 10:36 am

pharma marketing

AlveoGene debuts to develop inhaled gene therapy technology

Pharmaphorum

Thu, 09/14/23 - 10:01 am

lentiviral vectors

NICE changes its mind on Lilly's Mounjaro for diabetes

Pharmaphorum

Fri, 09/8/23 - 10:09 am

Novo Nordisk launches Wegovy for obese patients in UK

Pharmaceutical Business Review

Tue, 09/5/23 - 11:25 am

The BMJ's editor-in-chief wants action on pharma payments to leading doctor education groups in the UK

Fierce Pharma

Sun, 08/20/23 - 05:13 pm

pharma industry

physician payments

Haleon plots massive layoffs in UK and beyond to save cost: report

Fierce Pharma

Thu, 07/13/23 - 08:50 pm

consumer healthcare

FourPlus to create mixed-reality training platform for biopharma and healthcare sectors

Biopharma Reporter

Tue, 07/11/23 - 10:15 am

BMS’ Sotyktu cleared for NHS use in psoriasis

Pharmaphorum

Thu, 06/29/23 - 11:33 am

Bristol Myers Squibb

AstraZeneca, Merck's Lynparza picks up new NICE recommendation

Fierce Pharma

Fri, 06/9/23 - 10:15 am

fallopian tube cancer

GSK faces strike threat in UK, again, after workers pan pay raise

Fierce Pharma

Wed, 04/19/23 - 09:57 pm

GSK told to pay higher royalties to AZ on Zejula sales

Pharmaphorum

Thu, 04/6/23 - 11:37 am

AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE

Fierce Pharma

Wed, 03/29/23 - 09:58 am

‘Huge boost for biotech companies’: UK life sciences industry welcomes new enhanced R&D tax relief rate

Biopharma Reporter

Thu, 03/23/23 - 11:11 am

Novartis pulls the plug on UK-based cardiovascular study

Endpoints

Wed, 03/22/23 - 09:11 pm

clinical trials

Moderna selects Oxfordshire as location for U.K.-based mRNA manufacturing facility

Medical Marketing and Media

Mon, 03/6/23 - 11:17 pm

Moderna Therapeutics

drug manufacturing

UK could allow reciprocal drug approvals with US FDA as soon as 2024

Endpoints

Thu, 02/16/23 - 04:52 pm

Novo Nordisk apologizes for not disclosing sponsorship of anti-obesity training

Financial Times

Mon, 02/13/23 - 10:44 am

Jazz wins reimbursement nod from NICE for cannabinoid med Epidyolex

Fierce Pharma

Wed, 02/1/23 - 10:12 pm

Jazz Pharmaceuticals

After years of back-and-forth, Gilead's CAR-T Yescarta sways England's cost watchdog NICE

Fierce Pharma

Thu, 01/26/23 - 10:40 am

Gilead Sciences

Construction on Merck's London research hub set to begin in April 2023

Endpoints

Wed, 01/25/23 - 10:40 pm

Pages